According to www.techsciresearch.com latest Report- Global hydroxychloroquine and chloroquine market is expected to grow at a robust pace during the forecast period, with the market size expected to double in 2020. Hydroxychloroquine and chloroquine are commonly available in the market under the brand name Aralen and Plaquenil, respectively. Report URL- https://www.techsciresearch.com/report/chloroquine-and-hydroxychloroquine-market/4609.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
2015 – 2030
GLOBAL HYDROXYCHLOROQUINE & CHLOROQUINE
MARKET
FORECAST & OPPORTUNITIES

2. 2
Scope of Report
Product of Interest (POI): Hydroxychloroquine & Chloroquine
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2030
Year Range
TYPE
ROUTE OF
ADMINISTRATION
• Oral
• Intravenous
REGION
• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa
• Injectables
• Tablets
Global Hydroxychloroquine & Chloroquine market is expected to grow at a formidable rate during
the forecast period. Chloroquine is commonly available in the market under the generic brand name
Aralen. The global Hydroxychloroquine & Chloroquine market is driven by the increasing use of the
drug for treating various diseases. Recently, it has been identified though not approved by the FDA
that the drug can be helpful in the treatment of novel coronavirus disease. Based on type, market
can be segregated into injectables and tablets.
Market Segmentation
END-USE
• Rheumatoid Arthritis
• Malaria
• COVID-19
• Others
STRENGTH
• 250mg
• 500mg

3. 3
Table of Contents
S. No. Contents
1. Product Overview
2. Research Methodology
3. Analyst View
4. Voice of Customer
4.1. Brand Awareness (Aided/Unaided)
4.2. Product Awareness
4.3. Customer Satisfaction Analysis
4.4. Unmet Needs/Challenges
5. Global Hydroxychloroquine & Chloroquine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Injectables, Tablets)
5.2.2. By Route of Administration (Oral, Intravenous)
5.2.3. By Strength (250mg, 500mg)
5.2.4. By Application (Rheumatoid Arthritis, Malaria, COVID-19, Others)
5.2.5. By Company (2019)
5.2.6.
By Region (Asia-Pacific, North America, Europe, South America, Middle East &
Africa)
5.3. Market Attractiveness Index

4. 4
Table of Contents
S. No. Contents
6. Asia-Pacific Hydroxychloroquine & Chloroquine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2 By Application
6.2.3. By Country (China, India, Australia, Japan, South Korea)
6.2.3.1. China Hydroxychloroquine & Chloroquine Market Outlook
6.2.3.1.1. Market Size & Forecast
6.2.3.1.1.1. By Value
6.2.3.1.2. Market Share & Forecast
6.2.3.1.2.1. By Type
6.2.3.1.2.2. By Application
6.2.3.2. India Hydroxychloroquine & Chloroquine Market Outlook
6.2.3.2.1. Market Size & Forecast
6.2.3.2.1.1. By Value
6.2.3.2.2. Market Share & Forecast
6.2.3.2.2.1. By Type
6.2.3.2.2.2. By Application

5. 5
Table of Contents
S. No. Contents
6.2.3.3. Australia Hydroxychloroquine & Chloroquine Market Outlook
6.2.3.3.1. Market Size & Forecast
6.2.3.3.1.1. By Value
6.2.3.3.2. Market Share & Forecast
6.2.3.3.2.1. By Type
6.2.3.3.2.2. By Application
6.2.3.4. Japan Hydroxychloroquine & Chloroquine Market Outlook
6.2.3.4.1. Market Size & Forecast
6.2.3.4.1.1. By Value
6.2.3.4.2. Market Share & Forecast
6.2.3.4.2.1. By Type
6.2.3.4.2.2. By Application
6.2.3.5. South Korea Hydroxychloroquine & Chloroquine Market Outlook
6.2.3.5.1. Market Size & Forecast
6.2.3.5.1.1. By Value
6.2.3.5.2. Market Share & Forecast
6.2.3.5.2.1. By Type
6.2.3.5.2.2. By Application

6. 6
Table of Contents
S. No. Contents
7. North America Hydroxychloroquine & Chloroquine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country (United States, Mexico, Canada)
7.2.3.1.
United States Hydroxychloroquine & Chloroquine Market
Outlook
7.2.3.1.1. Market Size & Forecast
7.2.3.1.1.1. By Value
7.2.3.1.2. Market Share & Forecast
7.2.3.1.2.1. By Type
7.2.3.1.2.2. By Application
7.2.3.2. Mexico Hydroxychloroquine & Chloroquine Market Outlook
7.2.3.2.1. Market Size & Forecast
7.2.3.2.1.1. By Value
7.2.3.2.2. Market Share & Forecast
7.2.3.2.2.1. By Type
7.2.3.2.2.2. By Application

7. 7
Table of Contents
S. No. Contents
7.2.3.3. Canada Hydroxychloroquine & Chloroquine Market Outlook
7.2.3.3.1. Market Size & Forecast
7.2.3.3.1.1. By Value
7.2.3.3.2. Market Share & Forecast
7.2.3.3.2.1. By Type
7.2.3.3.2.2. By Application
8. Europe Hydroxychloroquine & Chloroquine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2 By Application
8.2.3. By Country (France, Germany, United Kingdom, Italy, Spain)
8.2.3.1. France Hydroxychloroquine & Chloroquine Market Outlook
8.2.3.1.1. Market Size & Forecast
8.2.3.1.1.1. By Value
8.2.3.1.2. Market Share & Forecast
8.2.3.1.2.1. By Type
8.2.3.1.2.2. By Application

8. 8
Table of Contents
S. No. Contents
8.2.3.2. Germany Hydroxychloroquine & Chloroquine Market Outlook
8.2.3.2.1. Market Size & Forecast
8.2.3.2.1.1. By Value
8.2.3.2.2. Market Share & Forecast
8.2.3.2.2.1. By Type
8.2.3.2.2.2. By Application
8.2.3.3.
United Kingdom Hydroxychloroquine & Chloroquine Market
Outlook
8.2.3.3.1. Market Size & Forecast
8.2.3.3.1.1. By Value
8.2.3.3.2. Market Share & Forecast
8.2.3.3.2.1. By Type
8.2.3.3.2.2. By Application
8.2.3.4. Italy Hydroxychloroquine & Chloroquine Market Outlook
8.2.3.4.1. Market Size & Forecast
8.2.3.4.1.1. By Value
8.2.3.4.2. Market Share & Forecast
8.2.3.4.2.1. By Type
8.2.3.4.2.2. By Application

9. 9
Table of Contents
S. No. Contents
8.2.3.5. Spain Hydroxychloroquine & Chloroquine Market Outlook
8.2.3.5.1. Market Size & Forecast
8.2.3.5.1.1. By Value
8.2.3.5.2. Market Share & Forecast
8.2.3.5.2.1. By Type
8.2.3.5.2.2. By Application
9. South America Hydroxychloroquine & Chloroquine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Country (Brazil, Argentina, Colombia)
9.2.3.1. Brazil Hydroxychloroquine & Chloroquine Market Outlook
9.2.3.1.1. Market Size & Forecast
9.2.3.1.1.1. By Value
9.2.3.1.2. Market Share & Forecast
9.2.3.1.2.1. By Type
9.2.3.1.2.2. By Application

10. 10
Table of Contents
S. No. Contents
9.2.3.2. Argentina Hydroxychloroquine & Chloroquine Market Outlook
9.2.3.2.1. Market Size & Forecast
9.2.3.2.1.1. By Value
9.2.3.2.2. Market Share & Forecast
9.2.3.2.2.1. By Type
9.2.3.2.2.2. By Application
9.2.3.3. Colombia Hydroxychloroquine & Chloroquine Market Outlook
9.2.3.3.1 Market Size & Forecast
9.2.3.3.1.1. By Value
9.2.3.3.2. Market Share & Forecast
9.2.3.3.2.1. By Type
9.2.3.3.2.2. By Application
10. Middle East & Africa Hydroxychloroquine & Chloroquine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2 By Application
10.2.3. By Country (South Africa, Saudi Arabia, UAE)

11. 11
Table of Contents
S. No. Contents
10.2.3.1.
South Africa Hydroxychloroquine & Chloroquine Market
Outlook
10.2.3.1.1. Market Size & Forecast
10.2.3.1.1.1. By Value
10.2.3.1.2. Market Share & Forecast
10.2.3.1.2.1. By Type
10.2.3.1.2.2. By Application
10.2.3.2.
Saudi Arabia Hydroxychloroquine & Chloroquine Market
Outlook
10.2.3.2.1. Market Size & Forecast
10.2.3.2.1.1. By Value
10.2.3.2.2. Market Share & Forecast
10.2.3.2.2.1. By Type
10.2.3.2.2.2. By Application
10.2.3.3. UAE Hydroxychloroquine & Chloroquine Market Outlook
10.2.3.3.1. Market Size & Forecast
10.2.3.3.1.1. By Value
10.2.3.3.2. Market Share & Forecast
10.2.3.3.2.1. By Type
10.2.3.3.2.2. By Application

12. 12
Table of Contents
S. No. Contents
10.2.3.4. Kuwait Hydroxychloroquine & Chloroquine Market Outlook
10.2.3.4.1. Market Size & Forecast
10.2.3.4.1.1. By Value
10.2.3.4.2. Market Share & Forecast
10.2.3.4.2.1. By Type
10.2.3.4.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Pricing Analysis
14. Competitive Landscape (Leading Company Profiles)
15. Policy and Regulatory Landscape
16. Strategic Recommendations
17. About Us & Disclaimer

13. RESEARCHMETHODOLOGY

14. 14
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data
Collection
Developing list
of respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global
Hydroxychloroquine &
Chloroquine market,
overall market size and
segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global
Hydroxychloroquine &
Chloroquine market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Final Conclusion
✓ Market Participants
✓ Key Strengths
✓ LinkedIn
✓ TechSci Internal
Database
✓ Factiva
✓ Hoovers
Paid Sources
✓ Company Websites
✓ Company Annual
Reports
✓ White Paper Study
✓ Financial Reports
✓ Investor
Presentations
✓ Regulatory Body
✓ Associations, etc.
Secondary
Research
Primary Research

15. 15
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global Hydroxychloroquine & Chloroquine market. The
team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increasing use of the drug
for treating various diseases. The study includes market forecasting, which would enable our clients to take better decisions while planning their
strategy to achieve sustainability in the global Hydroxychloroquine & Chloroquine market.
Methodology Followed for Calculation of Market Size:
• Market Size By Value: Market size, in terms of Value, for the year 2019 was calculated based on information collected through exhaustive
secondary research and primary surveys, with various key opinion leaders/stakeholders, such as Hydroxychloroquine & Chloroquine manufacturer &
supplier companies, channel partners, market influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 Hydroxychloroquine & Chloroquine manufacturer & supplier companies, 45 – 50 channel partners, 80 –
100 end users, and 15 – 20 Industry experts and other value chain stakeholders in the global Hydroxychloroquine & Chloroquine market to obtain
the overall market size for 2015-2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size
was averaged out, to arrive at the market size data during 2014-2019.

16. 16
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by type, by route of administration, by strength, by
application, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares
generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were
further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by type, by route of administration, by strength, by application, by company and by region were calculated based on the responses
received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from
various technologies of Hydroxychloroquine & Chloroquine. The final shares were calculated by taking the geometric mean of the responses
gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in
SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global
Hydroxychloroquine & Chloroquine market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis

17. 17
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used
the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that
the figures compiled are only for the organized market including market share data.
Partial List of Companies Interviewed Key Secondary Sources
▪ ARTECEF B.V.
▪ Fishman Chemical, LLC
▪ Uniprix Inc.
▪ Bayer AG
▪ Abcam Inc.
▪ Recipharm
▪ Teva Pharmaceuticals
▪ Mylan NV
▪ Abbott
▪ Novartis AG
▪ World Bank
▪ TechSci Research Proprietary Database & Knowledge
Repository
▪ Company Annual Reports
▪ Industry Magazines
▪ Industry Reports
▪ News Dailies
▪ Credible Paid Databases

18. 18
INDUSTRY BRIEF
According to TechSci Research report, “Global Hydroxychloroquine and Chloroquine Market By Type, By Route of Administration, By Strength, By Application, By Region,
Competition, Forecast & Opportunities, 2030”, the global hydroxychloroquine and chloroquine market is projected to reach $ 285 million in 2020, predominantly on account of
rising use of the drug in treating novel coronavirus COVID-19. Though, it has not been proven clinically that the drug can be used in treating coronavirus, but it has been
identified that the drug is helpful in improving the early symptoms of the disease, especially the respiratory problems. Globally, Ipca and Cadila are among the top manufacturers
of these drugs.
The global hydroxychloroquine and chloroquine market are segmented based on type, route of administration, strength, application and region. Based on type, the market can be
categorized into injectables and tablets. The tablets segment is expected to dominate the market during the forecast period since these are cost effective. Based on route of
administration, the market can be bifurcated into oral and intravenous. The oral segment is expected to dominate the market since the drug is generally consumed orally in the
form of tablets. Based on application, the market can be categorized into rheumatoid arthritis, malaria, COVID-19 and others. The COVID-19 segment is expected to register the
highest growth during forecast period since it has been identified that the drug can be used to treat the disease, though not clinically proven. Additionally, studies suggest that it is
helpful in treating some symptoms of the disease and is being used widely in the treatment guidelines of COVID-19. Countries such as China, South Korea and Belgium have
added hydroxychloroquine and chloroquine in their coronavirus disease treatment guidelines. Also, studies suggest that the drug has been helpful in treating few cases of the
disease in France. Due to rising spread of the pandemic, FDA issued an Emergency Use Authorization for the treatment of novel coronavirus disease (COVID-19). Ipca
Laboratories Ltd, Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Rising Pharma Holdings Inc, Abcam plc, Mylan N.V, and Abbott are some of the
leading players operating in global chloroquine market.
“North America is expected to register significant growth in the hydroxychloroquine and chloroquine market during the forecast period, owing to the use of drug for treating
COVID-19. Additionally, the drug is being used in the coronavirus treatment guidelines in various other countries. If it gets proven clinically that the drug can be used for the
treatment of COVID-19, then this is expected to create lucrative opportunities for the market players in foreseeable future.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.

19. 19
SAMPLE DATA - SNAPSHOT
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 16.00 17.00 18.00 19.00 20
2015 2019 2020E 2024F 2030F
By Value (USD Million)
Global Hydroxychloroquine & Chloroquine Market Size, By Value (USD Million), 2015-2030F
CAGR By Value
XX%
CAGR By Value
YY%
Europe Hydroxychloroquine & Chloroquine Market Share, By Application, By Value, 2015–2030F
25%25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2017
2019
2021F
2023F
2025F
2027F
2029F
Rheumatoid Arthritis Malaria COVID-19 Others
Germany Hydroxychloroquine & Chloroquine Market Share, By Type, By Value, 2015-2030F
50%50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
50%
2015
2017
2019
2021F
2023F
2025F
2027F
2029F
Injectables Tables

20. 20
REPORT ORDERING
License Type Price
Electronic Access - Single User License $4450
Electronic Access - Multi-User License $5450
Custom Research License $9450
Report Price
To View Sample OR Purchase Report
Report Name: GLOBAL HYDROXYCHLOROQUINE & CHLOROQUINE MARKET
FORECAST & OPPORTUNITIES
2015 – 2030

21. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the
market.
Related Reports
• Global Chloroquine Market By Type (Injectables, Capsules, Tablets), By Route of Administration (Oral v/s Intravenous), By Dosage (5mg, 500mg,
1000mg), By Application (Arthrophlogosis, Malaria, COVID-19, Others), By Region, Forecast & Opportunities, 2030
• Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET), By Application (Cardiology,
Respiratory, Orthopaedics, Others), By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Others), By Route of Administration (Oral,
Intravenous, Nasal), By End-User (Hospitals, Diagnostic centers, Others), By Region, Forecast & Opportunities, 2030
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or
complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand.
However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results
obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together
with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com